Related Experiment Video
Updated: Mar 10, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Surveillance for hepatocellular carcinoma.
Álvaro Díaz-González1, Alejandro Forner1
1Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clinic Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Barcelona, Spain; Network for Biomedical Research in Hepatic and Digestive Diseases (CIBERehd), Spain.
Regular screening for hepatocellular carcinoma (HCC) using ultrasound can significantly reduce cancer deaths in high-risk individuals. Implementing these surveillance programs is crucial for early detection and improved patient outcomes.
Area of Science:
- Hepatology
- Oncology
- Medical Screening
Background:
- Hepatocellular carcinoma (HCC) is a primary cause of mortality in patients with liver disease.
- Early detection through surveillance is recommended to reduce cancer-specific mortality.
- Semiannual abdominal ultrasound is the standard surveillance strategy for individuals at risk of HCC.
Purpose of the Study:
- To evaluate the effectiveness of hepatocellular carcinoma surveillance.
- To emphasize the importance of early detection in reducing cancer mortality.
- To advocate for the widespread implementation of HCC surveillance programs.
Main Methods:
- Review of evidence from randomized-controlled studies, prospective and retrospective analyses, and modeling studies.
- Assessment of current scientific evidence supporting HCC surveillance.
- Identification of high-risk populations for HCC development.
Main Results:
- The benefit of HCC surveillance is supported by robust scientific evidence.
- Surveillance strategies, particularly semiannual ultrasound, are effective in managing HCC risk.
- Current evidence supports the recommendation and broad implementation of HCC surveillance.
Conclusions:
- HCC surveillance should be widely recommended and implemented based on current evidence.
- Further efforts are needed to enhance the diagnostic accuracy of screening tools.
- Improved identification of patients at risk is essential for cost-effective surveillance programs.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019